Increased nuclear expression and transactivation of vitamin D receptor by the cardiotonic steroid bufalin in human myeloid leukemia cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 114, Issue 3-5, 2009, Pages 144-151

  Amano, Yusuke ^a,b   Cho, Yoshitake ^a   Matsunawa, Manabu ^a   Komiyama, Kazuo ^b   Makishima, Makoto ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Bufalin; Cardiotonic steroid; Differentiation; Transcription; Vitamin D receptor

Indexed keywords

BUFALIN; CALCITRIOL; CATHELICIDIN; CYTOCHROME P450; CYTOCHROME P450 24A1; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ACETYLATION; ARTICLE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MYELOID LEUKEMIA; PHENOTYPE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSACTIVATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BUFANOLIDES; CARDIAC GLYCOSIDES; CELL DIFFERENTIATION; CELL NUCLEUS; CHOLECALCIFEROL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID; RECEPTORS, CALCITRIOL; SODIUM-POTASSIUM-EXCHANGING ATPASE; STEROID HYDROXYLASES; TRANSCRIPTIONAL ACTIVATION;

EID: 63049110881     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.01.022     Document Type: Article

References (51)

1. Makishima M., and Yamada S. Targeting the vitamin D receptor: advances in drug discovery. Expert Opin. Ther. Pat. 15 (2005) 1133-1145
2. Makishima M. Nuclear receptors as targets for drug development: regulation of cholesterol and bile acid metabolism by nuclear receptors. J. Pharmacol. Sci. 97 (2005) 177-183
3. Nagpal S., Na S., and Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr. Rev. 26 (2005) 662-687
4. 3 prolong survival time of mice inoculated with myeloid leukemia cells. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 201-204
5. Ma Y., Khalifa B., Yee Y.K., Lu J., Memezawa A., Savkur R.S., Yamamoto Y., Chintalacharuvu S.R., Yamaoka K., Stayrook K.R., Bramlett K.S., Zeng Q.Q., Chandrasekhar S., Yu X.-P., Linebarger J.H., Iturria S.J., Burris T.P., Kato S., Chin W.W., and Nagpal S. Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators. J. Clin. Invest. 116 (2006) 892-904
6. Ishizawa M., Matsunawa M., Adachi R., Uno S., Ikeda K., Masuno H., Shimizu M., Iwasaki K., Yamada S., and Makishima M. Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia. J. Lipid Res. 49 (2008) 763-772
7. Hozumi M. Differentiation therapy of leukemia: achievements, limitations and future prospects. Int. J. Hematol. 68 (1998) 107-129
8. Krenn L., and Kopp B. Bufadienolides from animal and plant sources. Phytochemistry 48 (1998) 1-29
9. Zhang L., Nakaya K., Yoshida T., and Kuroiwa Y. Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers. Cancer Res. 52 (1992) 4634-4641
10. Schoner W., and Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am. J. Physiol. Cell. Physiol. 293 (2007) C509-C536
11. Nakano H., Matsunawa M., Yasui A., Adachi R., Kawana K., Shimomura I., and Makishima M. Enhancement of ligand-dependent vitamin D receptor transactivation by the cardiotonic steroid bufalin. Biochem. Pharmacol. 70 (2005) 1479-1486
12. Horie A., Akimoto M., Tsumura H., Makishima M., Taketani T., Yamaguchi S., and Honma Y. Induction of differentiation of myeloid leukemia cells in primary culture in response to lithocholic acid acetate, a bile acid derivative, and cooperative effects with another differentiation inducer, cotylenin A. Leuk. Res. 32 (2008) 1112-1123
13. Tavangar K., Hoffman A.R., and Kraemer F.B. A micromethod for the isolation of total RNA from adipose tissue. Anal. Biochem. 186 (1990) 60-63
14. 3 derivatives with adamantane or lactone ring side chains are cell type-selective vitamin D receptor modulators. Mol. Pharmacol. 71 (2007) 1298-1311
15. Schreiber E., Matthias P., Muller M.M., and Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17 (1989) 6419
16. 3. J. Mol. Biol. 350 (2005) 65-77
17. Yamada K., Hino K., Tomoyasu S., Honma Y., and Tsuruoka N. Enhancement by bufalin of retinoic acid-induced differentiation of acute promyelocytic leukemia cells in primary culture. Leuk. Res. 22 (1998) 589-595
18. Plum L.A., Prahl J.M., Ma X., Sicinski R.R., Gowlugari S., Clagett-Dame M., and DeLuca H.F. Biologically active noncalcemic analogs of 1α,25-dihydroxyvitamin D with an abbreviated side chain containing no hydroxyl. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 6900-6904
19. 3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology 149 (2008) 3656-3667
20. Wu-Wong J.R., Nakane M., Ma J., Dixon D., and Gagne G. Vitamin D receptor (VDR) localization in human promyelocytic leukemia cells. Leuk. Lymphoma 47 (2006) 727-732
21. 3 target genes. Mol. Endocrinol. 19 (2005) 2685-2695
22. 3. FASEB J. 19 (2005) 1067-1077
23. Seuter S., Vaisanen S., Radmark O., Carlberg C., and Steinhilber D. Functional characterization of vitamin D responding regions in the human 5-lipoxygenase gene. Biochim. Biophys. Acta 1771 (2007) 864-872
24. Ishii Y., Kasukabe T., and Honma Y. Immediate up-regulation of the calcium-binding protein S100P and its involvement in the cytokinin-induced differentiation of human myeloid leukemia cells. Biochim. Biophys. Acta 1745 (2005) 156-165
25. Urahama N., Ito M., Sada A., Yakushijin K., Yamamoto K., Okamura A., Minagawa K., Hato A., Chihara K., Roeder R.G., and Matsui T. The role of transcriptional coactivator TRAP220 in myelomonocytic differentiation. Genes Cells 10 (2005) 1127-1137
26. Nasu K., Nishida M., Ueda T., Takai N., Bing S., Narahara H., and Miyakawa I. Bufalin induces apoptosis and the G0/G1 cell cycle arrest of endometriotic stromal cells: a promising agent for the treatment of endometriosis. Mol. Hum. Reprod. 11 (2005) 817-823
27. Masuda Y., Kawazae N., Nakajo S., Yoshida T., Kuroiwa Y., and Nakaya K. Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leuk. Res. 19 (1995) 549-556
28. Watabe M., Masuda Y., Nakajo S., Yoshida T., Kuroiwa Y., and Nakaya K. The cooperative interaction of two different signaling pathways in response to bufalin induces apoptosis in human leukemia U937 cells. J. Biol. Chem. 271 (1996) 14067-14073
29. Watabe M., Ito K., Masuda Y., Nakajo S., and Nakaya K. Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells. Oncogene 16 (1998) 779-787
30. Michigami T., Suga A., Yamazaki M., Shimizu C., Cai G., Okada S., and Ozono K. Identification of amino acid sequence in the hinge region of human vitamin D receptor that transfers a cytosolic protein to the nucleus. J. Biol. Chem. 274 (1999) 33531-33538
31. Gocek E., Kielbinski M., and Marcinkowska E. Activation of intracellular signaling pathways is necessary for an increase in VDR expression and its nuclear translocation. FEBS Lett. 581 (2007) 1751-1757
32. 3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin. Mol. Endocrinol. 13 (1999) 1686-1694
33. Rosenfeld M.G., Lunyak V.V., and Glass C.K. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 20 (2006) 1405-1428
34. 3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J. Bone Miner. Res. 20 (2005) 305-317
35. Zhang L., Nakaya K., Yoshida T., and Kuroiwa Y. Bufalin as a potent inducer of differentiation of human myeloid leukemia cells. Biochem. Biophys. Res. Commun. 178 (1991) 686-693
36. Dvela M., Rosen H., Feldmann T., Nesher M., and Lichtstein D. Diverse biological responses to different cardiotonic steroids. Pathophysiology 14 (2007) 159-166
37. +-ATPase and cardiac steroids in the regulation of endocytosis. Am. J. Physiol. Cell. Physiol. 293 (2007) C885-C896
38. 3 is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Invest. 110 (2002) 229-238
39. Xiang W., Kong J., Chen S., Cao L.-P., Qiao G., Zheng W., Liu W., Li X., Gardner D.G., and Li Y.C. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E125-E132
40. Giovannucci E., Liu Y., Hollis B.W., and Rimm E.B. 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch. Intern. Med. 168 (2008) 1174-1180
41. Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., Benjamin E.J., D'Agostino R.B., Wolf M., and Vasan R.S. Vitamin D deficiency and risk of cardiovascular disease. Circulation 117 (2008) 503-511
42. Imura A., Tsuji Y., Murata M., Maeda R., Kubota K., Iwano A., Obuse C., Togashi K., Tominaga M., Kita N., Tomiyama K., Iijima J., Nabeshima Y., Fujioka M., Asato R., Tanaka S., Kojima K., Ito J., Nozaki K., Hashimoto N., Ito T., Nishio T., Uchiyama T., Fujimori T., and Nabeshima Y. α-Klotho as a regulator of calcium homeostasis. Science 316 (2007) 1615-1618
43. Tsujikawa H., Kurotaki Y., Fujimori T., Fukuda K., and Nabeshima Y.-I. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol. Endocrinol. 17 (2003) 2393-2403
44. Urakawa I., Yamazaki Y., Shimada T., Iijima K., Hasegawa H., Okawa K., Fujita T., Fukumoto S., and Yamashita T. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444 (2006) 770-774
45. 3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am. J. Physiol. Gastrointest. Liver Physiol. 289 (2005) G1036-G1042
46. 3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter. Mol. Endocrinol. 21 (2007) 334-342
47. 3-induced DNA methylation suppresses the human CYP27B1 gene. Mol. Cell. Endocrinol. 265-266 (2007) 168-173
48. Ma H., Kou J., Zhu D., Yan Y., and Yu B. Liu-Shen-Wan, a traditional Chinese medicine, improves survival in sepsis induced by cecal ligation and puncture via reducing TNF-α levels, MDA content and enhancing macrophage phagocytosis. Int. Immunopharmacol. 6 (2006) 1355-1362
49. Cao Y., Zhao L., Liang Q., Bi K., Wang Y., and Luo G. Study of the determination and pharmacokinetics of bufadienolides in dog's plasma after administration of Liu-Shen-Wan by high performance liquid chromatography time-of-flight mass spectrometry. J. Chromatogr. B 853 (2007) 227-233
50. Beer T.M., Eilers K.M., Garzotto M., Egorin M.J., Lowe B.A., and Henner W.D. Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer. J. Clin. Oncol. 21 (2003) 123-128
51. Muindi J.R., Peng Y., Potter D.M., Hershberger P.A., Tauch J.S., Capozzoli M.J., Egorin M.J., Johnson C.S., and Trump D.L. Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel. Clin. Pharmacol. Ther. 72 (2002) 648-659